FR2582002B1 - Preparation a base d'acide hyaluronique chimiquement modifie et son procede d'obtention a partir de tissus animaux - Google Patents

Preparation a base d'acide hyaluronique chimiquement modifie et son procede d'obtention a partir de tissus animaux

Info

Publication number
FR2582002B1
FR2582002B1 FR8603144A FR8603144A FR2582002B1 FR 2582002 B1 FR2582002 B1 FR 2582002B1 FR 8603144 A FR8603144 A FR 8603144A FR 8603144 A FR8603144 A FR 8603144A FR 2582002 B1 FR2582002 B1 FR 2582002B1
Authority
FR
France
Prior art keywords
obtaining
hyaluronic acid
chemically modified
acid preparation
animal tissues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8603144A
Other languages
English (en)
French (fr)
Other versions
FR2582002A1 (fr
Inventor
Endre A Balazs
Adolf Leshchiner
Adelya Leshchiner
Philip Band
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomatrix Inc
Original Assignee
Biomatrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomatrix Inc filed Critical Biomatrix Inc
Publication of FR2582002A1 publication Critical patent/FR2582002A1/fr
Application granted granted Critical
Publication of FR2582002B1 publication Critical patent/FR2582002B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
FR8603144A 1985-03-12 1986-03-06 Preparation a base d'acide hyaluronique chimiquement modifie et son procede d'obtention a partir de tissus animaux Expired FR2582002B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/710,929 US4713448A (en) 1985-03-12 1985-03-12 Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues

Publications (2)

Publication Number Publication Date
FR2582002A1 FR2582002A1 (fr) 1986-11-21
FR2582002B1 true FR2582002B1 (fr) 1988-01-15

Family

ID=24856100

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8603144A Expired FR2582002B1 (fr) 1985-03-12 1986-03-06 Preparation a base d'acide hyaluronique chimiquement modifie et son procede d'obtention a partir de tissus animaux

Country Status (12)

Country Link
US (1) US4713448A (en:Method)
JP (2) JPS61207401A (en:Method)
AU (1) AU560956B2 (en:Method)
BE (1) BE904357A (en:Method)
CA (1) CA1276143C (en:Method)
CH (1) CH670092A5 (en:Method)
DE (3) DE3607897A1 (en:Method)
FR (1) FR2582002B1 (en:Method)
GB (1) GB2172295B (en:Method)
IT (1) IT1191981B (en:Method)
NL (1) NL186576C (en:Method)
SE (1) SE468830B (en:Method)

Families Citing this family (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5099013A (en) * 1985-03-12 1992-03-24 Biomatrix, Inc, Hylan preparation and method of recovery thereof from animal tissues
JPS62502833A (ja) * 1985-05-09 1987-11-12 カリス−ヒル、ディビッド ヒアルロン酸の製法
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
DE3684887D1 (de) * 1985-11-29 1992-05-21 Biomatrix Inc Arzneistoffabgabesysteme auf basis von hyaluronan, dessen derivaten und salzen sowie verfahren zu deren herstellung.
SE452469B (sv) * 1986-06-18 1987-11-30 Pharmacia Ab Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
AU610512B2 (en) * 1986-12-11 1991-05-23 Biomatrix Incorporated Improved hyaluronate-poly (ethylene oxide) mixtures
GB8713662D0 (en) * 1987-06-11 1987-07-15 Skandigen Ab Hyaluronic acid derivatives
US6610669B1 (en) 1987-09-18 2003-08-26 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US6174999B1 (en) 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
AU619760B2 (en) * 1987-12-10 1992-02-06 Genzyme Biosurgery Corporation Hylan preparation and method of recovery thereof from animal tissues
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
US5356883A (en) * 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
US5246698A (en) * 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5219360A (en) * 1991-05-10 1993-06-15 Fortis Research Corporation Mammary prosthesis fill and method of making same
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
CA2061567C (en) * 1992-02-20 1998-02-03 Rudolf E. Falk Use of hyaluronic acid to repair ischemia reperfusion damage
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
IT1260154B (it) * 1992-07-03 1996-03-28 Lanfranco Callegaro Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
US5616568A (en) * 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
US5690961A (en) 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5612321A (en) * 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
CA2273852C (en) 1996-12-06 2009-09-29 Amgen Inc. Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US6630457B1 (en) 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.
US20040048021A1 (en) * 1999-03-19 2004-03-11 Wan Barbara Y. F. Surface modification of substrates
US6610666B1 (en) 1999-11-08 2003-08-26 Bio-Hyos Ab Hyaluronan product and process for manufacturing thereof
US6521223B1 (en) 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
KR100375299B1 (ko) 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
WO2002068383A2 (en) * 2001-02-22 2002-09-06 Anika Therapeutics, Inc. Thiol-modified hyaluronan
KR100514582B1 (ko) * 2001-09-05 2005-09-13 한스바이오메드 주식회사 생체복원물질의 제조방법
MXPA01011542A (es) 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
US7186232B1 (en) * 2002-03-07 2007-03-06 Glaukoa Corporation Fluid infusion methods for glaucoma treatment
WO2003099346A2 (en) 2002-05-24 2003-12-04 Angiotech International Ag Compositions and methods for coating medical implants
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
CA2489712C (en) * 2002-06-21 2016-07-12 University Of Utah Research Foundation Crosslinked compounds and methods of making and using thereof
CA2496121C (en) * 2002-08-16 2010-03-30 Yoshiaki Miyata Stable formulations of hyaluronic acid for use in the therapeutic treatment of arthropathy
KR20040022760A (ko) * 2002-09-05 2004-03-18 주식회사 오스코텍 닭벼슬로부터 고순도 히아루론산의 추출방법
US6946551B2 (en) * 2003-03-12 2005-09-20 New Life Resources, Llc Preparation of hyaluronic acid from eggshell membrane
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
CA2536242A1 (en) * 2003-11-20 2005-06-09 Angiotech International Ag Implantable sensors and implantable pumps and anti-scarring agents
US20080176205A1 (en) * 2003-12-04 2008-07-24 University Of Utah Research Foundation Process and Formulation to Improve Viability of Stored Cells and Tissue
US7091191B2 (en) * 2003-12-19 2006-08-15 Ethicon, Inc. Modified hyaluronic acid for use in musculoskeletal tissue repair
US7625581B2 (en) * 2003-12-19 2009-12-01 Ethicon, Inc. Tissue scaffolds for use in muscoloskeletal repairs
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
WO2005066215A1 (en) * 2003-12-30 2005-07-21 Genzyme Corporation Cohesive gels form cross-linked hyaluronan and/or hylan, their preparation and use
DE102004002001A1 (de) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
US8580315B2 (en) * 2004-03-10 2013-11-12 Esm Technologies, Llc Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations
EP1750769B1 (en) * 2004-05-20 2013-01-23 Mentor Worldwide LLC Methods for making injectable polymer hydrogels
US7002007B2 (en) * 2004-05-28 2006-02-21 Calcigen Corporation Production of high molecular weight hyaluronates
ITMI20041373A1 (it) 2004-07-09 2004-10-09 Lima Lto S P A N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido
PT1817347T (pt) * 2004-11-24 2017-07-21 Albumedix As Resumo
JP5725594B2 (ja) 2004-12-30 2015-05-27 ジェンザイム・コーポレーション 関節内粘性補充のための療法
ITPD20050056A1 (it) 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
EP1926459B1 (en) 2005-09-19 2015-01-07 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
EP3028677A1 (en) 2005-12-14 2016-06-08 Anika Therapeutics Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
CA2633957A1 (en) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
CA2645227C (en) * 2006-03-07 2015-06-23 Prochon Biotech Ltd. Hydrazido derivatives of hyaluronic acid
ITPD20060219A1 (it) 2006-05-31 2007-12-01 Fidia Farmaceutici Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi
ES2391862T3 (es) * 2006-12-22 2012-11-30 Croma-Pharma Gesellschaft M.B.H. Uso de polisacaridos tiolados para el aumento de tejido
US8329870B2 (en) * 2007-01-04 2012-12-11 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
BRPI0811784A2 (pt) 2007-05-23 2011-05-10 Allergan Inc colÁgeno reticulado e uso do mesmo
US8658148B2 (en) * 2007-06-22 2014-02-25 Genzyme Corporation Chemically modified dendrimers
US20110077737A1 (en) * 2007-07-30 2011-03-31 Allergan, Inc. Tunably Crosslinked Polysaccharide Compositions
US8318695B2 (en) 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
JP2011503047A (ja) * 2007-11-13 2011-01-27 バイオ−テクノロジー ゼネラル（イスラエル）リミテッド 粘弾性生体高分子のための希釈濾過滅菌プロセス
MX2010005331A (es) 2007-11-16 2010-08-11 Vicept Therapeutics Inc Composiciones y metodos para tratamiento de purpura.
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US9161970B2 (en) 2007-12-12 2015-10-20 Allergan, Inc. Dermal filler
US9044477B2 (en) 2007-12-12 2015-06-02 Allergan, Inc. Botulinum toxin formulation
WO2009077399A1 (en) * 2007-12-19 2009-06-25 Evonik Goldschmidt Gmbh Crosslinked hyaluronic acid in emulsion
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US9228027B2 (en) 2008-09-02 2016-01-05 Allergan Holdings France S.A.S. Threads of Hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
MX2011003557A (es) 2008-10-02 2011-09-01 Lrr & D Ltd Vendas para heridas con capa de interfaz.
CN101721349B (zh) 2008-10-16 2011-07-20 常州百瑞吉生物医药有限公司 可注射原位交联水凝胶及其制备方法和用途
CZ2008705A3 (cs) 2008-11-06 2010-04-14 Cpn S. R. O. Zpusob prípravy DTPA sítovaných derivátu kyseliny hyaluronové a jejich modifikace
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US8273725B2 (en) 2009-09-10 2012-09-25 Genzyme Corporation Stable hyaluronan/steroid formulation
CZ2009836A3 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US8586562B2 (en) 2010-03-12 2013-11-19 Allergan Industrie, Sas Fluid compositions for improving skin conditions
EP3520827B1 (en) 2010-03-22 2022-05-25 Allergan, Inc. Cross-linked hydrogels for soft tissue augmentation
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
CZ20101001A3 (cs) 2010-12-31 2012-02-08 Cpn S.R.O. Hyaluronová vlákna, zpusob jejich prípravy a použití
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
WO2012167079A2 (en) 2011-06-03 2012-12-06 Allergan, Inc. Dermal filler compositions including antioxidants
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
DE102011077393A1 (de) * 2011-06-10 2012-12-13 Johannes Reinmüller Antiinfektives Mittel
US10865383B2 (en) 2011-07-12 2020-12-15 Lineage Cell Therapeutics, Inc. Methods and formulations for orthopedic cell therapy
PT2742070T (pt) 2011-08-10 2021-11-22 Glycores 2000 Srl Hialuronato de baixo peso molecular reticulado, resistente à degradação
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
FR2983483B1 (fr) 2011-12-02 2014-11-14 Vivacy Lab Procede de substitution et reticulation simultanees d'un polysaccharide via ses fonctions hydroxyles
CZ2012136A3 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
KR101240518B1 (ko) 2012-03-26 2013-03-11 주식회사 제네웰 생체 적합성 고분자를 이용한 이식용 재료
ES2661575T3 (es) 2012-03-30 2018-04-02 The Board Of Regents Of The University Of Oklahoma Producción de polímeros de heparosano de peso molecular alto y métodos de producción y uso de los mismos
ITPD20120098A1 (it) 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
ITPD20120173A1 (it) 2012-05-31 2013-12-01 Fidia Farmaceutici "nuovo sistema di rilascio di proteine idrofobiche"
WO2013185934A1 (en) * 2012-06-15 2013-12-19 Merz Pharma Gmbh & Co. Kgaa Method of preparing a composition based on hyaluronic acid
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
CN102863631B (zh) * 2012-09-29 2013-11-13 杭州嘉伟生物制品有限公司 外科整形用组织填充剂交联透明质酸钠凝胶及其制备方法
CZ2012842A3 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
RU2015133465A (ru) 2013-01-11 2017-02-16 Карбилан Терапьютикс, Инк. Стабилизированные композиции, содержащие гиалуроновую кислоту
US9255173B2 (en) 2013-03-15 2016-02-09 Lake Region Manufacturing, Inc. Oxirane (ethylene oxide) polyurethane coatings
US9714361B2 (en) 2013-03-15 2017-07-25 Lake Region Manfacturing, Inc. Oxirane (ethylene oxide) polyurethane coatings
CZ2014150A3 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
WO2016128550A1 (en) 2015-02-13 2016-08-18 Allergan Industrie, Sas Implants for sculpting, augmenting or correcting facial features such as the chin
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ306479B6 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
KR20170090965A (ko) * 2016-01-29 2017-08-08 한미약품 주식회사 복합 히알루론산 가교물 및 그 제조방법
EP3415586B1 (en) * 2016-02-12 2022-11-30 Laimu Corporation Wound treatment agent and method for producing same
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
WO2018143736A1 (ko) 2017-02-02 2018-08-09 (주)앰틱스바이오 갈롤기로 수식된 히알루론산 유도체를 기재로 하는 하이드로젤 및 이의 용도
KR20210057129A (ko) 2018-09-13 2021-05-20 알레간 인코포레이티드 클로스트리디움 독소-히알루론산 조성물
US10899944B2 (en) 2018-10-29 2021-01-26 Lake Region Manufacturing, Inc. Polyurethane urea-containing adipic acid dihydrazide where active hydrogens react with the epoxy group found on glycidol to form a diol
KR102400586B1 (ko) 2018-12-07 2022-05-23 한미약품 주식회사 히알루론산 가교물, 히알루론산 수화 겔 및 이들의 제조방법
US12090248B2 (en) 2018-12-07 2024-09-17 Hanmi Pharm. Co., Ltd. Crosslinked hyaluronic acid, hyaluronic acid hydrogel, and method for producing crosslinked hyaluronic acid and hyaluronic acid hydrogel
WO2022147084A1 (en) 2020-12-30 2022-07-07 Convatec Technologies Inc. Surface treatment system and method for subcutaneous device
KR20220106283A (ko) 2021-01-22 2022-07-29 (주)앰틱스바이오 자가 가교형 히알루론산 유도체 기반 창상피복재
EP4444418A1 (de) 2021-12-09 2024-10-16 Beiersdorf AG Topisch applizierbare zubereitung zur verbesserung des hautzustandes
DE102022202547A1 (de) 2021-12-09 2023-06-15 Beiersdorf Aktiengesellschaft Topisch applizierbare Zubereitung zur Verbesserung des Hautzustandes
IT202100032111A1 (it) 2021-12-22 2023-06-22 Fidia Farm Spa Nuovi sostituti biocompatibili dell’umor vitreo
DE102023201528A1 (de) 2023-02-21 2024-08-22 Beiersdorf Aktiengesellschaft Körpermilch
DE102023201536A1 (de) 2023-02-21 2024-08-22 Beiersdorf Aktiengesellschaft Körpermilch
WO2024223513A1 (de) 2023-04-27 2024-10-31 Beiersdorf Ag Retinolhaltige kosmetische zubereitung mit guter hautverträglichkeit
WO2024223517A1 (de) 2023-04-27 2024-10-31 Beiersdorf Ag Retinolhaltige kosmetische zubereitung mit guter stabilität, hautverträglichkeit und wirksamkeit
WO2024223515A1 (de) 2023-04-27 2024-10-31 Beiersdorf Ag Retinolhaltige kosmetische zubereitung mit guter stabilität und hautverträglichkeit
DE102023203936A1 (de) 2023-04-27 2024-10-31 Beiersdorf Aktiengesellschaft Retinolhaltige kosmetische Zubereitung mit guter Hautverträglichkeit
CN118812877B (zh) * 2024-06-17 2025-02-14 弘知生物科技(浙江)有限公司 一种含聚胍类高分子聚合物的长效抑菌水凝胶及制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT252264B (de) * 1965-03-17 1967-02-10 Etapharm Chem Pharm Lab Ges M Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
US4152170A (en) * 1975-06-18 1979-05-01 Sumitomo Chemical Company, Ltd. Cross-linked pullulan
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4048435A (en) * 1976-07-12 1977-09-13 National Starch And Chemical Corporation Method for the preparation of highly substituted granular starches
US4272522A (en) * 1979-10-15 1981-06-09 Balazs Endre A Method for stimulating phagocytic activity and synergistic compositions therefor
US4303676A (en) * 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
SU950735A1 (ru) * 1980-10-28 1982-08-15 Саратовский Ордена Трудового Красного Знамени Государственный Университет Им.Н.Г.Чернышевского Способ получени гиалуроновой кислоты
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
US4500676A (en) * 1983-12-15 1985-02-19 Biomatrix, Inc. Hyaluronate modified polymeric articles
CA1238043A (en) * 1983-12-15 1988-06-14 Endre A. Balazs Water insoluble preparations of hyaluronic acid and processes therefor
US4487865A (en) * 1983-12-15 1984-12-11 Biomatrix, Inc. Polymeric articles modified with hyaluronate
US4629623A (en) * 1984-06-11 1986-12-16 Biomatrix, Inc. Hyaluronate-poly (ethylene oxide) compositions and cosmetic formulations thereof
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4605691A (en) * 1984-12-06 1986-08-12 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels

Also Published As

Publication number Publication date
JPH01198602A (ja) 1989-08-10
CA1276143C (en) 1990-11-13
FR2582002A1 (fr) 1986-11-21
AU560956B2 (en) 1987-04-30
DE3645191C2 (en:Method) 1992-12-10
IT8619684A0 (it) 1986-03-10
GB8601304D0 (en) 1986-02-26
AU5289186A (en) 1986-09-18
GB2172295A (en) 1986-09-17
JPH0353321B2 (en:Method) 1991-08-14
AU7618087A (en) 1987-10-29
JPS61207401A (ja) 1986-09-13
BE904357A (fr) 1986-06-30
DE3645226C2 (en:Method) 1993-07-15
NL186576C (nl) 1991-01-02
NL8600644A (nl) 1986-10-01
SE468830B (sv) 1993-03-29
SE8601135L (sv) 1986-09-13
NL186576B (nl) 1990-08-01
SE8601135D0 (sv) 1986-03-11
IT8619684A1 (it) 1987-09-10
AU583464B2 (en) 1989-04-27
DE3607897C2 (en:Method) 1992-02-27
GB2172295B (en) 1989-01-05
US4713448A (en) 1987-12-15
IT1191981B (it) 1988-03-31
DE3607897A1 (de) 1986-09-18
CH670092A5 (en:Method) 1989-05-12

Similar Documents

Publication Publication Date Title
FR2582002B1 (fr) Preparation a base d'acide hyaluronique chimiquement modifie et son procede d'obtention a partir de tissus animaux
FR2633940B3 (fr) Scleroglucane traite au glyoxal et son procede d'obtention
FR2604895B1 (fr) Procede d'obtention de revetements ophtalmologiques en collagene et revetements prepares par ce procede
FR2583982B1 (fr) Produit medicamenteux obtenu a partir du thymus et son procede d'obtention
FR2648743B1 (fr) Materiau de construction obtenu a partir de residus vegetaux et son procede d'obtention
FR2771089B1 (fr) Procede de production d'acide acrylique
FR2601455B1 (fr) Nouveaux reactifs biologiques en phase solide et leur procede d'obtention
FR2648318B1 (fr) Fromages hyposodes et leur procede d'obtention
FR2626884B1 (fr) Procede de preparation de n-phosphonomethyl-imino-diacetique et de chlorure d'acide en resultant
FR2620702B1 (fr) Procede de preparation d'irones naturelles
FR2643647B1 (fr) Procede microbiologique d'obtention de methylcetones
FR2615185B1 (fr) Procede de preparation de trifluoromethyltoluene a partir d'halomethylbenzotrifluorure
FR2622714B1 (fr) Procede d'analyse de mammographie
FR2743072B1 (fr) Procede de preparation d'acides perfluoroalcanecarboxyliques et perfluoroalcanesulfoniques
FR2609287B1 (fr) Procede de preparation d'un acide 4-trifluoromethyl-2-nitrobenzoique et d'un nouvel isomere
FR2650272B1 (fr) Procede de dedoublement d'intermediaires interessants dans la preparation de diltiazem
FR2590254B1 (fr) Procede d'obtention de l'ester ethylique de l'acide apovincanimique
RO92739A2 (ro) Procedeu de obtinere a acidului gluconic
RO96796A2 (ro) Procedeu de obtinere a acidului tricloracetic
RO93136A2 (ro) Procedeu de obtinere a criolitului
FR2595353B1 (fr) Procede de preparation d'encainide
RO92799A2 (ro) Procedeu de obtinere a sulfului insolubil
RO92957A2 (ro) Procedeu de obtinere a acidului 4-nitrobenzoic
RO92750A2 (ro) Procedeu de obtinere a acidului 3-clor-4-aliloxi-fenilacetic
FR2636333B1 (fr) Procede d'obtention de collagene a partir de peaux fraiches

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property